Magnesium Replacement IV in the Emergency Department
Immediate Treatment Protocol
For acute symptomatic hypomagnesemia in the ED, administer 1-2 g IV magnesium sulfate over 15 minutes, followed by maintenance infusion of 1 g/hour for 24 hours if needed. 1
Dosing by Clinical Indication
Severe hypomagnesemia (symptomatic):
- Loading dose: 1-2 g IV over 15 minutes 1
- Maintenance: 1 g/hour continuous infusion for 24 hours 1
- Alternative for severe deficiency: Up to 5 g (approximately 40 mEq) added to 1 L of D5W or NS for slow IV infusion over 3 hours 2
Mild magnesium deficiency:
Life-threatening arrhythmias (Torsades de Pointes):
- 2 g IV magnesium sulfate as first-line therapy, regardless of serum magnesium level 1
- Administer over 15 minutes for polymorphic VT with QT prolongation 1
Critical Safety Considerations
Renal insufficiency is the most important contraindication:
- Maximum dose in severe renal insufficiency: 20 g over 48 hours 2
- Frequent serum magnesium monitoring is mandatory in renal impairment 2
- Avoid magnesium oxide in patients with renal insufficiency due to hypermagnesemia risk 3
Administration precautions:
- The 50% solution MUST be diluted to 20% or less concentration before IV infusion 2
- Rate should not exceed 150 mg/minute (1.5 mL of 10% solution) except in severe eclampsia with seizures 2
- Have calcium immediately available to counteract magnesium toxicity 1, 2
Monitoring Parameters
Target serum magnesium levels:
- Normal range: 1.3-2.2 mEq/L (1.5-2.5 mEq/L) 1, 2
- Therapeutic target: >0.6 mmol/L minimum 3
- For seizure control in eclampsia: 6 mg/100 mL 2
Clinical monitoring for toxicity:
- Deep tendon reflexes diminish when magnesium exceeds 4 mEq/L 2
- Reflexes may be absent at 10 mEq/L with risk of respiratory paralysis 2
- Monitor for flushing, hypotension, and bradycardia 1
Common Pitfalls to Avoid
Do not rely solely on serum magnesium levels:
- Serum magnesium may not accurately reflect intracellular stores 4, 5
- Approximately 50% of ICU patients have magnesium depletion despite normal serum levels 5
- Consider empiric therapy in high-risk patients even with normal serum levels 4
High-risk populations requiring empiric consideration:
- Poorly controlled diabetes mellitus 5
- Alcohol use disorder 5
- Severe diarrhea or malabsorption 5
- Patients on diuretics, pentamidine, or other magnesium-wasting medications 3, 5
Do not exceed maximum daily doses:
- Total daily dose should not exceed 30-40 g in 24 hours 2
- In renal insufficiency: maximum 20 g over 48 hours 2
Drug Interactions and Contraindications
CNS depressants:
- Reduce dosage of barbiturates, narcotics, or anesthetics when co-administering with magnesium due to additive CNS depression 2
Neuromuscular blocking agents:
- Excessive neuromuscular blockade can occur; administer concomitantly with extreme caution 2
Cardiac glycosides:
- Use extreme caution in digitalized patients due to risk of heart block if calcium is needed to treat magnesium toxicity 2
Special Populations
Pregnancy considerations:
- Continuous maternal administration beyond 5-7 days can cause fetal abnormalities including hypocalcemia and skeletal demineralization 2
- Newborns may show neuromuscular or respiratory depression if mother received continuous infusion >24 hours before delivery 2
Geriatric patients:
- Require reduced dosage due to impaired renal function 2
- Maximum 20 g in 48 hours for severe renal impairment 2
- Mandatory serum magnesium monitoring 2
Evidence-Based Indications in Emergency Medicine
Strong evidence supports magnesium use for:
- Severe asthma: 2 g IV over 20 minutes (diluted to ≤20% concentration) 1, 6
- Eclampsia/preeclampsia: 4-6 g loading dose over 20-30 minutes, then 1-2 g/hour maintenance 1, 6
- Torsades de pointes: 1-2 g IV bolus 3, 1, 6
Insufficient evidence for routine use in:
Hypokalemia Management Context
Critical interaction with potassium:
- Hypomagnesemia impairs correction of hypokalemia 3
- Hyperaldosteronism from sodium depletion increases renal loss of both magnesium and potassium 3
- Correct magnesium deficiency first before attempting to correct refractory hypokalemia 3
- Avoid bolus potassium administration in cardiac arrest suspected from hypokalemia 3